George Kurian - 27 Apr 2022 Form 4 Insider Report for Cigna Corp (CI)

Role
Director
Signature
By: Jill M. Stadelman, attorney-in-fact
Issuer symbol
CI
Transactions as of
27 Apr 2022
Transactions value $
$0
Form type
4
Filing time
29 Apr 2022, 18:11:07 UTC
Previous filing
19 Apr 2022
Next filing
16 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +757 +70.16% $0.00 1.84K 27 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 39 and 101 of Cigna's proxy statement filed with the SEC on March 18, 2022.

Remarks:

Exhibit List: EX-24 Power of Attorney poakurian.txt